Literature DB >> 10396605

The management of hypertensive disease in black patients.

C R Gibbs1, D G Beevers, G Y Lip.   

Abstract

The ethnic differences in the incidence, pathophysiology and management of hypertensive disease, are particularly pertinent to the Black or Afro-Caribbean populations, who have a high prevalence of hypertension and associated complications, such as strokes and renal impairment. Our understanding of the underlying pathophysiology of hypertensive disease and the optimal treatment of hypertension in Black patients continues to evolve, especially with the introduction of new drugs and the need for prognostic data in this ethnic population. We review the management of hypertensive disease in the black population, emphasizing race-related differences in the pathophysiology of hypertension and the importance of tailored management in this group of patients, including sensible application of non-pharmacological measures with effective antihypertensive agents. For example, diuretics and calcium antagonists are suitable first-line agents in black hypertensives, whilst beta-blockers and the ACE inhibitors tend to be less effective at lowering blood pressure, due to the low renin state in these patients.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10396605     DOI: 10.1093/qjmed/92.4.187

Source DB:  PubMed          Journal:  QJM        ISSN: 1460-2393


  15 in total

1.  Management of hypertension. Ideal body weight is not realistic goal for lifestyle intervention.

Authors:  J Wilding; G Williams
Journal:  BMJ       Date:  2000-02-26

Review 2.  Racial and ethnic differences in response to medicines: towards individualized pharmaceutical treatment.

Authors:  Valentine J Burroughs; Randall W Maxey; Richard A Levy
Journal:  J Natl Med Assoc       Date:  2002-10       Impact factor: 1.798

3.  Proximal tumors are associated with greater mortality in colon cancer.

Authors:  Robert Wong
Journal:  J Gen Intern Med       Date:  2010-11       Impact factor: 5.128

4.  Implications of the angiotensin converting enzyme gene insertion/deletion polymorphism in health and disease: a snapshot review.

Authors:  Paul R Gard
Journal:  Int J Mol Epidemiol Genet       Date:  2010-03-20

5.  A community-based study of hypertension and cardio-metabolic syndrome in semi-urban and rural communities in Nigeria.

Authors:  Ifeoma I Ulasi; Chinwuba K Ijoma; Obinna D Onodugo
Journal:  BMC Health Serv Res       Date:  2010-03-19       Impact factor: 2.655

6.  The enormity of chronic kidney disease in Nigeria: the situation in a teaching hospital in South-East Nigeria.

Authors:  Ifeoma I Ulasi; Chinwuba K Ijoma
Journal:  J Trop Med       Date:  2010-06-02

7.  CYP3A5 as a candidate gene for hypertension: no support from an unselected indigenous West African population.

Authors:  D L Fisher; J Plange-Rhule; M Moreton; J B Eastwood; S M Kerry; F Micah; A Johnston; F P Cappuccio; I A M MacPhee
Journal:  J Hum Hypertens       Date:  2016-06-23       Impact factor: 3.012

Review 8.  Aldosterone and aldosterone antagonism in systemic hypertension.

Authors:  William H Frishman; Charles T Stier
Journal:  Curr Hypertens Rep       Date:  2004-06       Impact factor: 5.369

9.  Effects of demographics on the antihypertensive efficacy of triple therapy with amlodipine, valsartan, and hydrochlorothiazide for moderate to severe hypertension.

Authors:  David A Calhoun; Yves Lacourcière; Nora Crikelair; Yan Jia; Robert D Glazer
Journal:  Curr Med Res Opin       Date:  2013-07-01       Impact factor: 2.580

10.  Effectiveness and safety of valsartan in children aged 6 to 16 years with hypertension.

Authors:  Thomas Wells; Jeffrey Blumer; Kevin E C Meyers; Jose P R Neto; Rejane Meneses; Mieczysław Litwin; Johan Vande Walle; Susan Solar-Yohay; Victor Shi; Guangyang Han
Journal:  J Clin Hypertens (Greenwich)       Date:  2011-03-18       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.